Expanded Access Program of Ultratrace Iobenguane I131 for Malignant Relapsed/Refractory Pheochromocytoma/Paraganglioma
Clinical trial NCT02961491 · APPROVED_FOR_MARKETING
Trial details
- NCT number
- NCT02961491
- Sponsor
- Molecular Insight Pharmaceuticals, Inc.
- Status
- APPROVED_FOR_MARKETING
- Study type
- EXPANDED_ACCESS
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.